Evidence map›Paper›PMID 42763332›Full record

ArticleEuropean radiology2026

Habitat imaging based on enhanced CT for predicting occult central lymph node metastasis in papillary thyroid carcinoma.

Wen Zhao, Zhijie Duan, Tengfei Ke, Zhiquan Han, Yizhen Zeng, Li Gao, Xinhui Yang, Weihan Cao, Wenyan Wei, Dan Han

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wen Zhao *Department of Medical lmaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Zhijie Duan *Department of Medical lmaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Tengfei Ke *Department of Radiology, Yunnan Cancer Hospital (The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan Campus), Kunming, China.
Zhiquan HanDepartment of Medical lmaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Yizhen ZengDepartment of Medical lmaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Li GaoDepartment of Medical lmaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Xinhui YangDepartment of Medical lmaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Weihan CaoDepartment of Ultrasonography, The First Affiliated Hospital of Kunming Medical University, Kunming, China. caoweihankm@163.com.
Wenyan WeiDepartment of Medical lmaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China. 769986303@qq.com.
Dan HanDepartment of Medical lmaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China. kmhandan@sina.com.ORCID http://orcid.org/0000-0002-0408-9175

Funding

Young Talent Fund of Yunnan Provincial Education Department 2025J0188Yunnan health training project of high level talents No. H-2025081Yunnan Provincial Department of Education Science Research Fund Project 2024J0209Yunnan Provincial Department of Education Science Research Fund Project 2024J0261
6 · The paper itself

Abstract

objectivesThis study aimed to develop a combined model based on clinical, intratumoral habitat, and peritumoral radiomic features to predict occult central lymph node metastasis (OCLNM) in patients with papillary thyroid carcinoma (PTC). MATERIALS AND

methodsThis retrospective study analysed preoperative enhanced CT images and clinical parameters from 219 PTC patients from two medical centers. The patients were divided into a training cohort from Center 1 (n = 154) and an external validation cohort from Center 2 (n = 65). Habitat radiomics features from the tumor and 3-mm peritumoral region were extracted from both arterial phase (AP) and venous phase (VP) CT images, respectively. Five machine learning (ML) methods were employed to construct models. The area under the curve (AUC) was used to evaluate the model performance, thereby selecting the best-performing ML model. Ultimately, a combined model was developed by integrating clinical factors with the optimal AP and VP habitat models.

resultsAge, TSH, and PLT were identified as independent predictors. Both the intratumoral habitat and peritumoral radiomics models based on LR exhibited excellent performance in the training and external validation cohorts (AUC: 0.820 and 0.805 in AP; 0.884 and 0.850 in VP). The combined model demonstrated superior predictive capability, achieving AUCs of 0.932 in the training cohort and 0.878 in the external validation cohort.

conclusionThe combined model integrating intratumoral habitat and peritumoral radiomics from enhanced CT images with clinical features provides a potential, non-invasive preoperative method for predicting OCLNM in PTC patients and may provide supplementary information for preoperative risk stratification. KEY POINTS: Question Accurate preoperative diagnosis of OCLNM in PTC is crucial for guiding dissection but remains an urgent clinical challenge. Findings A combined model integrating CT-based intratumoral habitats, peritumoral radiomics, and clinical factors achieved superior performance (AUC: 0.878) in predicting occult metastases across two centers. Clinical relevance This non-invasive model may serve as an adjunctive tool for preoperative risk stratification, providing supplementary information to support individualized surgical planning in patients with PTC.

Indexed as

Lymphatic metastasisRadiomicsThyroid cancer (papillary)Tomography (X-ray computed)

Identifiers

PMID42763332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.